Society for Healthcare Epidemiology of America Compendium updates 2022

Edward J Septimus, Edward J Septimus

Abstract

Purpose of review: Healthcare-associated infections (HAIs) are a leading cause of preventable harm in US hospitals. Hospitals are required to conduct surveillance and report selected HAIs, including central line-associated bloodstream infections, catheter-associated urinary tract infections, colon and abdominal hysterectomy surgical-site infections, methicillin-resistant Staphylococcus aureus bacteremia, and Clostridioides difficile infections, to the CDC's National Healthcare Safety Network.

Recent findings: Up until the COVID-19 pandemic, there was significant progress in reducing HAIs. However, the pandemic resulted in extraordinary challenges for infection prevention in hospitals. Increases in HAIs were observed throughout 2020 and 2021. The Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute Care Hospitals has recently been updated and provides common sense evidenced-based strategies to reduce HAIs.

Summary: The purpose of this review is to highlight important changes since the 2014 Compendium.

Conflict of interest statement

There are no conflicts of interest.

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.

Figures

Box 1
Box 1
no caption available

References

    1. Lastinger LM, Alvarez CR, Kofman A, et al. . Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2022; 1–5. doi: 10.1017/ice.2022.116.

    2. Data from the NHSN were analyzed to assess the impact of COVID-19 on the incidence of HAIs during 2021. HAIs were significantly higher than those during the prepandemic period. The incidence of HAIs was elevated during periods of high COVID-19 hospitalizations.

    1. Buetti N, Marschall J, Drees M, et al. . Strategies to prevent central line-associated bloodstream infections in acute-care hospitals: 2022 Update. Infect Control Hospital Epidemiol 2022; 43:553–569.

    2. This publication provides practical recommendations in a concise, practical format to assist acute-care hospitals in implementing and prioritizing CLABSI prevention efforts. The documents contain important updates from the 2014 document.

    1. Huang SS, Septimus E, Kleinman K, et al. . ABATE Infection trial team. Chlorhexidine versus routine bathing to prevent multidrug-resistant organisms and all-cause bloodstream infections in general medical and surgical units (ABATE Infection trial): a cluster-randomised trial. Lancet 2019; 393:1205–1215.
    1. Tien K-L, Sheng W-H, Shieh S-C, et al. . Chlorhexidine bathing to prevent central line-associated bloodstream infections in hematology units: a prospective, controlled cohort study. Clin Infect Dis 2019; 71:556–563.
    1. Rickard CM, Marsh NM, Larsen EN, et al. . Effect of infusion set replacement intervals on catheter-related bloodstream infections (RSVP): a randomised, controlled, equivalence (central venous access device)-non-inferiority (peripheral arterial catheter) trial. Lancet 2021; 397:1447–1458.
    1. Magill SS, O’Leary E, Janelle SJ, et al. . Changes in prevalence of healthcare-associated infections in U.S. hospitals. New Engl J Med 2018; 379:1732–1744.
    1. Augustus Oglesby HJ, Cataldo SH, Pedro MJ. Automated near real-time ventilator data feedback reduces incidence of ventilator-associated events: a retrospective observational study. Crit Care Explor 2021; 3:e0379.
    1. Klompas M, Branson R, Cawcutt K, et al. . Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 update. Infect Control Hospital Epidemiol 2022; 43:687–713.

    2. This publication highlights practical recommendations to assist acute-care hospitals to prioritize and implement strategies to prevent VAP, VAEs, and NV-HAP (a new section) in adults, children, and neonates.

    1. Zhao T, Wu X, Zhang Q, et al. . Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 2020; 12:CD008367.
    1. Sozkes S, Sozkes S. Use of toothbrushing in conjunction with chlorhexidine for preventing ventilator-associated pneumonia: a random-effect meta-analysis of randomized controlled trials. Int J Dent Hyg 2021; 21:389–397.
    1. Deschepper M, Waegeman W, Eeckloo K, et al. . Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med 2018; 44:1017–1026.
    1. Hammond NE, Myburgh J, Seppelt I, et al. . Association between selective decontamination of the digestive tract and in-hospital mortality in intensive care unit patients receiving mechanical ventilation: a systematic review and meta-analysis. JAMA 2022; 328:1922–1934.

    2. This is the latest systemic review of the use of SDD in prevention of VAP. Among adults in the ICU treated with mechanical ventilation, the use of SDD compared with standard care or placebo was associated with lower hospital mortality. SDD is not recommended in ICUs with high level of antimicrobial resistance.

    1. Johnstone J, Meade M, Lauzier F, et al. . Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial. JAMA 2021; 326:1024–1033.
    1. Zilberberg MD, Nathanson BH, Puzniak LA, Shorr AF. Descriptive epidemiology and outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2012-2019. Crit Care Med 2022; 50:460–468.

    2. This article examines the epidemiology and outcomes of VAP and NV-HAP. Hospital mortality was highest among patients with VAP and lowest in NV-HAP. However, NV-HAP is associated with higher mortality and length of stay compared with patients without NV-HAP.

    1. Warren C, Medei MK, Wood B, Schutte D. A nurse-driven oral care protocol to reduce hospital-acquired pneumonia. Am J Nurs 2019; 119:44–51.
    1. Lacerna CC, Patey D, Block L, et al. . A successful program preventing nonventilator hospital-acquired pneumonia in a large hospital system. Infect Control Hosp Epidemiol 2020; 41:547–552.
    1. Ståhl A, Westerdahl E. Postoperative physical therapy to prevent hospital-acquired pneumonia in patients over 80 years undergoing hip fracture surgery-a quasi-experimental study. Clin Interv Aging 2020; 15:1821–1829.
    1. Mattingly AS, Rose L, Eddington HS, et al. . Trends in US surgical procedures and healthcare system response to policies curtailing elective surgical operations during the COVID-19 pandemic. JAMA Netw Open 2021; 4:e2138038.
    1. Bode LGM, Kluytmans JAJW, Wertheim HFL, et al. . Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. New Engl J Med 2010; 362:9–17.
    1. Schweizer ML, Chiang HY, Septimus E, et al. . Association of a bundled intervention with surgical site infections among patients undergoing cardiac, hip, or knee surgery. JAMA 2015; 313:2162–2171.
    1. Septimus EJ. Nasal decolonization to reduce surgical site infections. Med Res Arch 2023; 10: DOI: 10.18103/mra.v10i12.3476.
    1. Mackeen AD, Packard RE, Ota E, et al. . Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev 2014; (12):CD009516.
    1. Haas DM, Morgan S, Contreras K, Enders S. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev 2020; 4:CD007892.
    1. Lam PW, Tarighi P, Elligsen M, et al. . Self-reported beta-lactam allergy and the risk of surgical site infection: a retrospective cohort study. Infect Control Hosp Epidemiol 2020; 41:438–443.
    1. Sousa-Pinto B, Blumenthal KG, Courtney L, et al. . Assessment of the frequency of dual allergy to penicillins and cefazolin: a systematic review and meta-analysis. JAMA Surg 2021; 156:e210021.

    2. This article is a systemic review assessing beta-lactam allergy. Their findings suggest that most patients with a penicillin allergy history may safely receive cefazolin. This finding supports using a beat-lactam like cefazolin over alternative agents.

    1. Miranda D, Mermel LA, Dellinger EP. Perioperative antibiotic prophylaxis: surgeons as antimicrobial stewards. J Am Coll Surg 2020; 231:766–768.
    1. Rollins KE, Javanmard-Emamghissi H, Acheson AG, Lobo DN. The role of oral antibiotic preparation in elective colorectal surgery: a meta-analysis. Ann Surg 2019; 270:43–58.
    1. Ritter B, Herlyn PKE, Mittlmeier T, Herlyn A. Preoperative skin antisepsis using chlorhexidine may reduce surgical wound infections in lower limb trauma surgery when compared to povidone-iodine - a prospective randomized trial. Am J Infect Control 2020; 48:167–172.
    1. Tuuli MG, Liu J, Stout MJ, et al. . A randomized trial comparing skin antiseptic agents at cesarean delivery. New Engl J Med 2016; 374:647–655.
    1. Kwon S, Thompson R, Dellinger P, et al. . Importance of perioperative glycemic control in general surgery: a report from the Surgical Care and Outcomes Assessment Program. Ann Surg 2013; 257:8–14.
    1. Shaffer SK, Tubog TD, Kane TD, Stortroen NE. Supplemental oxygen and surgical site infection in colorectal surgery: a systematic review and meta-analysis. AANA J 2021; 89:245–253.
    1. Smith BK, Roberts RH, Frizelle FA. O(2) no longer the Go(2): a systematic review and meta-analysis comparing the effects of giving perioperative oxygen therapy of 30% FiO(2) to 80% FiO(2) on surgical site infection and mortality. World J Surg 2020; 44:69–77.
    1. Weiner-Lastinger LM, Abner S, Edwards JR, et al. . Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015–2017. Infect Control Hosp Epidemiol 2020; 41:1–18.
    1. Kourtis AP, Hatfield K, Baggs J, et al. . Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible staphylococcus aureus bloodstream infections - United States. MMWR Morb Mortal Weekly Rep 2019; 68:214–219.
    1. Karanika S, Paudel S, Grigoras C, et al. . Systematic review and meta-analysis of clinical and economic outcomes from the implementation of hospital-based antimicrobial stewardship programs. Antimicrob Agents Chemother 2016; 60:4840–4852.
    1. Baur D, Gladstone BP, Burkert F, et al. . Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017; 17:990–1001.
    1. Haessler S, Martin EM, Scales ME, et al. . Stopping the routine use of contact precautions for management of MRSA and VRE at three academic medical centers: an interrupted time series analysis. Am J Infect Control 2020; 48:1466–1473.
    1. Martin EM, Colaianne B, Bridge C, et al. . Discontinuing MRSA and VRE contact precautions: defining hospital characteristics and infection prevention practices predicting safe de-escalation. Infect Control Hosp Epidemiol 2022; 43:1595–1602.

    2. This study was an interrupted time series in 15 acute-care hospitals. No statistically significant rate changes occurred between intervention and nonintervention hospitals. However, all successful hospitals had low baseline MRSA and VRE HAI rates and high hand hygiene adherence.

    1. Huang SS, Singh R, McKinnell JA, et al. . Project CLEAR Trial. Decolonization to reduce postdischarge infection risk among MRSA carriers. New Engl J Med 2019; 380:638–650.
    1. Ericson JE, Popoola VO, Smith PB, et al. . Burden of invasive Staphylococcus aureus infections in hospitalized infants. JAMA Pediatr 2015; 169:1105–1111.
    1. Huang YC, Lien RI, Lin TY. Effect of mupirocin decolonization on subsequent methicillin-resistant Staphylococcus aureus infection in infants in neonatal intensive care units. Pediatr Infect Dis J 2015; 34:241–245.
    1. Ristagno EH, Bryant KA, Boland LF, et al. . Effect of intranasal mupirocin prophylaxis on methicillin-resistant Staphylococcus aureus transmission and invasive staphylococcal infections in a neonatal intensive care unit. Infect Control Hospital Epidemiol 2018; 39:741–745.
    1. Kociolek LK, Gerding DN, Carrico R, et al. . Strategies to prevent Clostridioides difficile infections in acute-care hospitals: 2022 update. Infect Control Hosp Epidemiol 2023; 44:527–549.

    2. This section provides a very nice review on CDI. Most of the recommendations are considered low quality of evidence. However, encouraging the appropriate use antimicrobials through implementation of an antimicrobial stewardship program is now considered moderate level of evidence.

    1. Kelly CR, Fischer M, Allegretti JR, et al. . ACG clinical guidelines: prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol 2021; 116:1124–1147.
    1. Hogan CA, Hitchcock MM, Frost S, et al. . Clinical outcomes of treated and untreated C. difficile PCR-positive/toxin-negative adult hospitalized patients: a quasi-experimental noninferiority study. J Clin Microbiol 2022; 60:e02187–e2221.

    2. The investigators performed a quasi-experimental noninferiority study comparing clinical outcomes of PCR+/CT-toxin- individuals by reporting PCR result only (most patients treated) with reporting CT-toxin result only (most patients untreated). This study supports the safety of withholding antibiotics for selected hospitalized individuals with suspected CDI but negative toxin.

    1. Weiner-Lastinger LM, Pattabiraman V, Konnor RY, et al. . The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: a summary of data reported to the National Healthcare Safety Network. Infect Control Hosp Epidemiol 2022; 43:12–25.
    1. Schreiber PW, Sax H, Wolfensberger A, et al. . The preventable proportion of healthcare-associated infections 2005-2016: systematic review and meta-analysis. Infect Control Hosp Epidemiol 2018; 39:1277–1295.
    1. Calderwood M, Anderson DJ, Bratzler DW, et al. . Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2023; doi:10:1017/ice.2023.67.

    2. This section reviews updated essential practices including decolonization, glucose control, combination parenteral and oral antimicrobials to reduce risk of SSIs following colon and rectal surgery, and vaginal prep before C-sections to name a few. Supplemental oxygen has now been moved to an unresolved issue based on additional studies.

    1. Popovich K, Aureden K, Cal Ham D, et al. . Strategies to prevent methicillin-resistant 3 staphylococcus aureus transmission and infection in acute care hospitals. Infect Control Hosp Epidemiol 2022; [in press].

    2. This update discusses the pro and con of using contact precautions for patients colonized or infected with MRSA, implementing an antimicrobial stewardship program, and use of active surveillance and decolonization strategies including preoperative screening for high-risk procedures.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel